GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pilulka Lekarny AS (XPRA:PINK) » Definitions » Interest Coverage

Pilulka Lekarny AS (XPRA:PINK) Interest Coverage : 0 (At Loss) (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Pilulka Lekarny AS Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Pilulka Lekarny AS's Operating Income for the six months ended in Dec. 2024 was Kč-85 Mil. Pilulka Lekarny AS's Interest Expense for the six months ended in Dec. 2024 was Kč-12 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Pilulka Lekarny AS's Interest Coverage or its related term are showing as below:


XPRA:PINK's Interest Coverage is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 8.17
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Pilulka Lekarny AS Interest Coverage Historical Data

The historical data trend for Pilulka Lekarny AS's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Pilulka Lekarny AS Interest Coverage Chart

Pilulka Lekarny AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Interest Coverage
1.32 - - - -

Pilulka Lekarny AS Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24
Interest Coverage 1.32 - - - -

Competitive Comparison of Pilulka Lekarny AS's Interest Coverage

For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pilulka Lekarny AS's Interest Coverage Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Pilulka Lekarny AS's Interest Coverage falls into.


;
;

Pilulka Lekarny AS Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pilulka Lekarny AS's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, Pilulka Lekarny AS's Interest Expense was Kč-12 Mil. Its Operating Income was Kč-85 Mil. And its Long-Term Debt & Capital Lease Obligation was Kč2 Mil.

Pilulka Lekarny AS did not have earnings to cover the interest expense.

Pilulka Lekarny AS's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Here, for the six months ended in Dec. 2024, Pilulka Lekarny AS's Interest Expense was Kč-12 Mil. Its Operating Income was Kč-85 Mil. And its Long-Term Debt & Capital Lease Obligation was Kč2 Mil.

Pilulka Lekarny AS did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Pilulka Lekarny AS  (XPRA:PINK) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Pilulka Lekarny AS Interest Coverage Related Terms

Thank you for viewing the detailed overview of Pilulka Lekarny AS's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Pilulka Lekarny AS Business Description

Traded in Other Exchanges
N/A
Address
Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.

Pilulka Lekarny AS Headlines

From GuruFocus

LEE DANNER & BASS INC Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor 10-31-2022

Top 5 4th Quarter Trades of LEE DANNER & BASS INC

By GuruFocus Research GuruFocus Editor 02-02-2023